• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲复杂皮肤及软组织感染住院患者对抗生素治疗的早期反应:REACH研究分析

Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.

作者信息

Garau Javier, Blasi Francesco, Medina Jesús, McBride Kyle, Ostermann Helmut

机构信息

Department of Medicine, Hospital Universitari Mutua de Terrassa, Plaza Doctor Robert 5, 08221, Terrassa, Barcelona, Spain.

Department of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Ospedale Maggiore, Policlinico Cà Granda Milano, Milan, Italy.

出版信息

BMC Infect Dis. 2015 Feb 19;15:78. doi: 10.1186/s12879-015-0822-2.

DOI:10.1186/s12879-015-0822-2
PMID:25879713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4352248/
Abstract

BACKGROUND

The treatment of complicated skin and soft tissue infections (cSSTI) is challenging and many patients do not receive adequate first-line therapy. REACH (REtrospective Study to Assess the Clinical Management of Patients With Moderate-to-Severe cSSTI or Community-Acquired Pneumonia in the Hospital Setting) was a retrospective observational study of cSSTI patients in real-life settings in European hospitals. In this analysis, we review characteristics and outcomes of patients with an early response (≤72 hours) compared with those without an early response to treatment. We also compare the results according to two differing definitions of early response, one of which (Definition 1) requires resolution of fever within 72 hours, in line with previous US FDA guidelines.

METHODS

Patients were adults hospitalized with cSSTIs 2010-2011 and requiring treatment with intravenous antibiotics. Clinical management, clinical outcomes and healthcare resource use were assessed using a descriptive analysis approach.

RESULTS

The analysis set included 600 patients, of which 363 showed early response with Definition 1 and 417 with Definition 2. Initial treatment modification was frequent, and highest in patients without early response (48.1% with Definition 1). Patients without early response were more likely to have diabetes than those with early response (31.6% vs. 22.9%, respectively) and to suffer from more severe disease (e.g. skin necrosis: 14.8% and 7.7%, respectively), to be infected with difficult-to-treat microorganisms and to have recurrent infections. Furthermore, patients without early response had a higher rate of adverse clinical outcomes (e.g. septic shock) and higher use of healthcare resources. The results obtained with the two definitions for early response were largely similar.

CONCLUSIONS

This study highlights the significance of early evaluation of patients in hospitals, in potentially preventing prolonged use of inappropriate or ineffective antibacterial therapy.

TRIAL REGISTRATION

NCT01293435 .

摘要

背景

复杂性皮肤和软组织感染(cSSTI)的治疗具有挑战性,许多患者未接受充分的一线治疗。REACH(评估医院环境中中重度cSSTI或社区获得性肺炎患者临床管理的回顾性研究)是一项针对欧洲医院实际环境中cSSTI患者的回顾性观察研究。在本分析中,我们回顾了有早期反应(≤72小时)的患者与无早期反应患者的特征和结局。我们还根据两种不同的早期反应定义比较了结果,其中一种定义(定义1)要求在72小时内退热,这与美国食品药品监督管理局(FDA)先前的指南一致。

方法

研究对象为2010 - 2011年因cSSTI住院且需要静脉使用抗生素治疗的成年患者。采用描述性分析方法评估临床管理、临床结局和医疗资源使用情况。

结果

分析数据集包括600例患者,其中363例符合定义1的早期反应,417例符合定义2的早期反应。初始治疗调整很常见,在无早期反应的患者中发生率最高(定义1组为48.1%)。无早期反应的患者比有早期反应的患者更易患糖尿病(分别为31.6%和22.9%),病情更严重(如皮肤坏死:分别为14.8%和7.7%),感染难治疗的微生物,且有复发性感染。此外,无早期反应的患者不良临床结局(如感染性休克)发生率更高,医疗资源使用更多。两种早期反应定义的结果基本相似。

结论

本研究强调了医院对患者进行早期评估的重要性,这可能有助于避免长期使用不适当或无效的抗菌治疗。

试验注册号

NCT01293435 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d4/4352248/77444565362a/12879_2015_822_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d4/4352248/77444565362a/12879_2015_822_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8d4/4352248/77444565362a/12879_2015_822_Fig1_HTML.jpg

相似文献

1
Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.欧洲复杂皮肤及软组织感染住院患者对抗生素治疗的早期反应:REACH研究分析
BMC Infect Dis. 2015 Feb 19;15:78. doi: 10.1186/s12879-015-0822-2.
2
Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.欧洲复杂皮肤和软组织感染住院患者的资源利用及弱势群体分析:REACH研究
J Med Econ. 2014 Oct;17(10):719-29. doi: 10.3111/13696998.2014.940423. Epub 2014 Jul 25.
3
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.欧洲复杂皮肤和软组织感染住院患者的当前管理(2010-2011 年):来自 REACH 研究的临床实践模式评估和抗生素的实际效果。
Clin Microbiol Infect. 2013 Sep;19(9):E377-85. doi: 10.1111/1469-0691.12235. Epub 2013 May 10.
4
Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study.社区获得性肺炎患者的早期与晚期治疗反应:REACH 研究分析。
Respir Res. 2014 Jan 22;15(1):6. doi: 10.1186/1465-9921-15-6.
5
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.住院患者中复杂性皮肤和软组织感染的流行病学和结局。
J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11. Epub 2011 Nov 23.
6
Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.欧洲各地为患有耐甲氧西林金黄色葡萄球菌复杂性皮肤和软组织感染的住院患者提供了早期转换/早期出院的机会。
Clin Microbiol Infect. 2014 Oct;20(10):993-1000. doi: 10.1111/1469-0691.12632. Epub 2014 May 15.
7
Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.欧洲多重耐药病原体的耐药机制和流行病学及替加环素在观察性研究中的疗效。
J Antimicrob Chemother. 2013 Jul;68 Suppl 2:ii45-55. doi: 10.1093/jac/dkt144.
8
Efficacy of tigecycline for the treatment of complicated skin and soft-tissue infections in real-life clinical practice from five European observational studies.来自五个欧洲观察性研究的替加环素治疗真实临床实践中复杂性皮肤和软组织感染的疗效。
J Antimicrob Chemother. 2013 Jul;68 Suppl 2:ii15-24. doi: 10.1093/jac/dkt141.
9
Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013.2008年至2013年中国南方住院患者复杂皮肤及软组织感染的流行病学与转归
PLoS One. 2016 Feb 26;11(2):e0149960. doi: 10.1371/journal.pone.0149960. eCollection 2016.
10
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.一项真实世界的欧洲研究:基于体重的抗生素剂量方案在治疗耐甲氧西林金黄色葡萄球菌引起的复杂性皮肤软组织感染中的应用。
Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S40-6. doi: 10.1016/j.cmi.2015.05.030. Epub 2015 Jul 20.

引用本文的文献

1
Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections.来自真实世界REDS研究的达巴万星治疗急性细菌性皮肤和皮肤结构感染住院患者的成本分析。
Glob Reg Health Technol Assess. 2025 Jun 9;12:151-157. doi: 10.33393/grhta.2025.3363. eCollection 2025 Jan-Dec.
2
The bacterial pathogen and resistance spectrum in a dermatological inpatient ward: a six-year, retrospective, epidemiological study.皮肤科住院病房的细菌病原体及耐药谱:一项为期六年的回顾性流行病学研究。
GMS Hyg Infect Control. 2022 Sep 2;17:Doc16. doi: 10.3205/dgkh000419. eCollection 2022.
3

本文引用的文献

1
Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.早期疗效评估指导万古霉素治疗耐甲氧西林金黄色葡萄球菌血流感染的管理。
Clin Ther. 2013 Jul;35(7):995-1004. doi: 10.1016/j.clinthera.2013.05.018. Epub 2013 Jul 2.
2
Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.欧洲复杂皮肤和软组织感染住院患者的当前管理(2010-2011 年):来自 REACH 研究的临床实践模式评估和抗生素的实际效果。
Clin Microbiol Infect. 2013 Sep;19(9):E377-85. doi: 10.1111/1469-0691.12235. Epub 2013 May 10.
3
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.
头孢洛林酯用于经验性治疗住院成年社区获得性皮肤及软组织感染患者:基于西班牙国家卫生系统视角的经济学分析
Clinicoecon Outcomes Res. 2022 Mar 18;14:149-161. doi: 10.2147/CEOR.S329494. eCollection 2022.
4
Incidence and mortality of necrotizing fasciitis in The Netherlands: the impact of group A Streptococcus.荷兰坏死性筋膜炎的发病率和死亡率:A 组链球菌的影响。
BMC Infect Dis. 2021 Dec 6;21(1):1217. doi: 10.1186/s12879-021-06928-5.
5
Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.关于医源性细菌感染的流行病学更新:重点关注复杂性皮肤和皮肤结构感染。
J Antimicrob Chemother. 2021 Nov 22;76(Suppl 4):iv2-iv8. doi: 10.1093/jac/dkab350.
6
Antibiotics in Necrotizing Soft Tissue Infections.坏死性软组织感染中的抗生素
Antibiotics (Basel). 2021 Sep 13;10(9):1104. doi: 10.3390/antibiotics10091104.
7
Thymoquinone-Loaded Polymeric Films and Hydrogels for Bacterial Disinfection and Wound Healing.用于细菌消毒和伤口愈合的载百里醌聚合物薄膜和水凝胶
Biomedicines. 2020 Sep 28;8(10):386. doi: 10.3390/biomedicines8100386.
8
Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials.达氟沙星治疗急性细菌性皮肤及皮肤结构感染的疗效与安全性:一项随机对照试验的系统评价与荟萃分析
Infect Drug Resist. 2019 May 27;12:1415-1423. doi: 10.2147/IDR.S202160. eCollection 2019.
9
Opportunities for antimicrobial stewardship in patients with acute bacterial skin and skin structure infections who are unsuitable for beta-lactam antibiotics: a multicenter prospective observational study.对不适合使用β-内酰胺类抗生素的急性细菌性皮肤及皮肤结构感染患者进行抗菌药物管理的机会:一项多中心前瞻性观察研究。
Ther Adv Infect Dis. 2019 Feb 4;6:2049936118823655. doi: 10.1177/2049936118823655. eCollection 2019 Jan-Dec.
10
A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study.静脉注射后序贯口服多氟喹诺酮与万古霉素联合氨曲南治疗急性细菌性皮肤及皮肤结构感染的疗效和安全性比较:一项 3 期、多国、双盲、随机研究。
Clin Infect Dis. 2018 Aug 16;67(5):657-666. doi: 10.1093/cid/ciy165.
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).治疗第 3 天的临床应答和住院的急性细菌性皮肤和皮肤结构感染(ABSSSI)患者的经济结局。
Curr Med Res Opin. 2013 Jul;29(7):869-77. doi: 10.1185/03007995.2013.803056. Epub 2013 May 23.
4
Initial treatment failure in patients with complicated skin and skin structure infections.复杂性皮肤和皮肤结构感染患者的初始治疗失败。
Surg Infect (Larchmt). 2013 Jun;14(3):304-12. doi: 10.1089/sur.2012.103. Epub 2013 Apr 16.
5
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.磷酸替加环素与利奈唑胺治疗急性细菌性皮肤和皮肤结构感染:ESTABLISH-1 随机试验。
JAMA. 2013 Feb 13;309(6):559-69. doi: 10.1001/jama.2013.241.
6
Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.开发社区获得性细菌性肺炎和急性细菌性皮肤和皮肤结构感染注册临床试验终点的进展:来自美国国立卫生研究院基金会生物标志物联盟的最新消息。
Clin Infect Dis. 2012 Oct;55(8):1114-21. doi: 10.1093/cid/cis566. Epub 2012 Jun 28.
7
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.CANVAS 1 和 2:头孢洛林酯氨噻肟与万古霉素加氨曲南治疗急性细菌性皮肤和皮肤结构感染的两项 3 期临床试验中第 3 天临床应答的分析。
Antimicrob Agents Chemother. 2012 May;56(5):2231-6. doi: 10.1128/AAC.05738-11. Epub 2012 Feb 6.
8
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.住院患者中复杂性皮肤和软组织感染的流行病学和结局。
J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11. Epub 2011 Nov 23.
9
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.CANVAS 2:评价头孢洛林酯治疗复杂性皮肤和皮肤结构感染患者的第二项 III 期、随机、双盲研究。
J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv53-iv65. doi: 10.1093/jac/dkq255.
10
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.CANVAS 1 研究:首个评估头孢洛林酯治疗复杂性皮肤和皮肤软组织感染的 III 期、随机、双盲研究。
J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv41-51. doi: 10.1093/jac/dkq254.